top of page
Abstract Fluid Design

Transforming advanced therapies into clinical reality

Built on 15+ years of proven GMP expertise in advanced cell therapy manufacturing

Scientists Collaborating

Advanced Therapy Manufacturing Platform

Citospin operates one of Spain’s most established ATMP manufacturing platforms, built within the country’s first clean room dedicated exclusively to advanced therapies. With more than 3,000 MSC treatments manufactured and over 20 clinical trials supported, our platform combines scientific expertise with GMP-grade precision.

Development & Clinical Manufacturing Services

We act as a strategic partner for advanced therapy programs, supporting process development, GMP manufacturing, regulatory documentation, and clinical supply coordination. Our experience spans autologous and allogeneic workflows, ensuring reliable execution from early development through clinical-stage production.

DNA Model Hands
Scientist Using Microscope

Emerging Programs & Innovation Pipeline

While our current clinical platform centers on bone marrow–derived MSCs, Citospin is actively expanding its research and development capabilities to support the next generation of advanced biological therapies.

aa74a0bb-d710-48f1-95af-de5902a76251.jpg

Why Partner With Citospin

bottom of page